Stock Scorecard

Stock Summary for Bionano Genomics Inc (BNGO) - $0.25 as of 11/20/2024 7:51:20 PM EST

Total Score

12 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for BNGO

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BNGO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BNGO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BNGO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BNGO (35 out of 90)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0

Latest News for for BNGO

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules 10/31/2024 8:30:00 PM
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Bionano Genomics ( NASDAQ:BNGO ) 10/31/2024 8:30:00 PM
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Bionano Genomics ( NASDAQ:BNGO ) 10/31/2024 12:00:00 PM
Bears are Losing Control Over Bionano Genomics ( BNGO ) , Here's Why It's a 'Buy' Now 9/6/2024 1:55:00 PM
Bionano Genomics ( BNGO ) Upgraded to Buy: Here's Why 8/13/2024 4:00:00 PM
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules 7/8/2024 9:25:00 PM
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules 7/5/2024 12:00:00 PM
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research 6/20/2024 12:00:00 PM
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis - Bionano Genomics ( NASDAQ:BNGO ) 5/9/2024 12:00:00 PM
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing - Bionano Genomics ( NASDAQ:BNGO ) 4/24/2024 12:00:00 PM

Financial Details for BNGO

Company Overview
Ticker BNGO
Company Name Bionano Genomics Inc
Country USA
Description Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 0.25
Price 4 Years Ago 30.80
Last Day Price Updated 11/20/2024 7:51:20 PM EST
Last Day Volume 2,238,618
Average Daily Volume 3,252,468
52-Week High 2.27
52-Week Low 0.20
Last Price to 52 Week Low 25.00%

Valuation Measures
Trailing PE N/A
Industry PE 27.34
Sector PE 40.32
5-Year Average PE -42.32
Free Cash Flow Ratio 2.08
Industry Free Cash Flow Ratio 102.40
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 1.43
Total Cash Per Share 0.12
Book Value Per Share Most Recent Quarter 2.10
Price to Book Ratio 0.48
Industry Price to Book Ratio 800.29
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 0.63
Industry Price to Sales Ratio Twelve Trailing Months 3.81
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics
Total Shares Outstanding 101,993,000
Market Capitalization 25,498,250
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -75.34%
Reported EPS 12 Trailing Months -2.30
Reported EPS Past Year -1.00
Reported EPS Prior Year -3.32
Net Income Twelve Trailing Months -135,783,000
Net Income Past Year -232,493,000
Net Income Prior Year -132,596,000
Quarterly Revenue Growth YOY -10.30%
5-Year Revenue Growth 20.96%
Operating Margin Twelve Trailing Months -2.03

Balance Sheet
Total Cash Most Recent Quarter 11,994,000
Total Cash Past Year 66,771,000
Total Cash Prior Year 113,195,000
Net Cash Position Most Recent Quarter 11,994,000
Net Cash Position Past Year 50,445,000
Long Term Debt Past Year 16,326,000
Long Term Debt Prior Year 16,326,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.85
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 96,157,000
Total Stockholder Equity Prior Year 249,398,000
Total Stockholder Equity Most Recent Quarter 48,868,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months -93,064,000
Free Cash Flow Per Share Twelve Trailing Months -0.91
Free Cash Flow Past Year -126,891,000
Free Cash Flow Prior Year -125,710,000

Options
Put/Call Ratio 0.04
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.03
MACD Signal -0.03
20-Day Bollinger Lower Band 0.18
20-Day Bollinger Middle Band 0.43
20-Day Bollinger Upper Band 0.68
Beta 2.38
RSI 27.46
50-Day SMA 0.87
150-Day SMA 9.72
200-Day SMA 23.77

System
Modified 11/20/2024 7:44:32 PM EST